The Role of Platelets in Diabetic Kidney Disease

被引:10
|
作者
Rustiasari, Ukhti Jamil [1 ,2 ,3 ]
Roelofs, Joris J. [1 ,2 ]
机构
[1] Univ Amsterdam, Amsterdam UMC, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Amsterdam Cardiovasc Sci, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Islam Indonesia, Fac Med, Dept Anat Pathol, Yogyakarta 55584, Indonesia
关键词
diabetes; diabetic kidney disease; diabetic nephropathy; platelets; platelet activation; biomarker; antiplatelet; SOLUBLE CD40 LIGAND; DRUG DILAZEP DIHYDROCHLORIDE; PLASMA BETA-THROMBOGLOBULIN; GLOMERULAR MESANGIAL CELL; FIBROBLAST-GROWTH-FACTOR; CHRONIC-RENAL-FAILURE; BERAPROST SODIUM; ACTIVATING-FACTOR; P-SELECTIN; ADHESION MOLECULES;
D O I
10.3390/ijms23158270
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diabetic kidney disease (DKD) is among the most common microvascular complications in patients with diabetes, and it currently accounts for the majority of end-stage kidney disease cases worldwide. The pathogenesis of DKD is complex and multifactorial, including systemic and intra-renal inflammatory and coagulation processes. Activated platelets play a pivotal role in inflammation, coagulation, and fibrosis. Mounting evidence shows that platelets play a role in the pathogenesis and progression of DKD. The potentially beneficial effects of antiplatelet agents in preventing progression of DKD has been studied in animal models and clinical trials. This review summarizes the current knowledge on the role of platelets in DKD, including the potential therapeutic effects of antiplatelet therapies.
引用
收藏
页数:35
相关论文
共 50 条
  • [31] THE ROLE OF ALDOSTERONE ANTAGONISM AGENTS IN DIABETIC KIDNEY DISEASE
    Wombwell, Eric
    Naglich, Andrew
    [J]. JOURNAL OF RENAL CARE, 2015, 41 (01) : 9 - 18
  • [32] Role of Nox2 in diabetic kidney disease
    You, Young-Hyun
    Okada, Shinichi
    Ly, San
    Jandeleit-Dahm, Karin
    Barit, David
    Namikoshi, Tamehachi
    Sharma, Kumar
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (07) : F840 - F848
  • [33] Role of Glycyrrhizin in the Reduction of Inflammation in Diabetic Kidney Disease
    Thakur, Vikram
    Nargis, Syeda
    Gonzalez, Mayra
    Pradhan, Swetak
    Terreros, Daniel
    Chattopadhyay, Munmun
    [J]. NEPHRON, 2017, 137 (02) : 137 - 147
  • [34] Targeting Inflammation in Diabetic Kidney Disease: Is There a Role for Pentoxifylline?
    Leehey, David J.
    [J]. KIDNEY360, 2020, 1 (04): : 292 - 299
  • [35] Physiological and pathophysiological signalling between the gut and the kidney: role in diabetic kidney disease
    Docherty, Neil G.
    le Roux, Carel W.
    [J]. EXPERIMENTAL PHYSIOLOGY, 2014, 99 (09) : 1138 - 1139
  • [36] The critical role of dysregulated autophagy in the progression of diabetic kidney disease
    Zhang, Ziwei
    Sun, Yuting
    Xue, Jiaojiao
    Jin, De
    Li, Xiangyan
    Zhao, Daqing
    Lian, Fengmei
    Qi, Wenxiu
    Tong, Xiaolin
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [37] Role of Glucose Metabolism and Mitochondrial Function in Diabetic Kidney Disease
    Stanton, Robert C.
    [J]. CURRENT DIABETES REPORTS, 2021, 21 (02)
  • [38] Role of TRPC6 in Progression of Diabetic Kidney Disease
    Staruschenko, Alexander
    Spires, Denisha
    Palygin, Oleg
    [J]. CURRENT HYPERTENSION REPORTS, 2019, 21 (07)
  • [39] Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease
    Christopher D. Wiley
    [J]. Current Diabetes Reports, 2020, 20
  • [40] The Emerging Role of Biomarkers in Diabetic and Hypertensive Chronic Kidney Disease
    Chaudhary, Kunal
    Phadke, Gautam
    Nistala, Ravi
    Weidmeyer, Charles E.
    McFarlane, Samy I.
    Whaley-Connell, Adam
    [J]. CURRENT DIABETES REPORTS, 2010, 10 (01) : 37 - 42